• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子作为免疫调节疗法对多发性硬化症心理影响的一种可能底物的作用。

The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

作者信息

Spirin N N, Kasatkin D S

机构信息

State Educational Institution of Higher Professional Education Yaroslavl Medical Academy, Russian Ministry of Health, Yaroslavl, Russia.

出版信息

Neurosci Behav Physiol. 2009 Jan;39(1):25-30. doi: 10.1007/s11055-008-9087-1.

DOI:10.1007/s11055-008-9087-1
PMID:19089638
Abstract

Changes in the emotional background make significant contributions to the clinical picture of multiple sclerosis (MS), seriously reducing patients' quality of life and hindering adaptation during the process of rehabilitation. The relationship between mental state and disease activity has been discussed in the world literature in recent years and the opinion that mental disorders in MS are pathogenetically based is increasingly widespread. The present article discusses the potential role of substances mediating immune responses-cytokines-in the effects of changes in the functional activity of the nervous system and psychoemotional status. The question of their likely involvement in the pathogenesis of the side effects of immunomodulatory therapy of MS with beta-interferons and glatiramer acetate is discussed.

摘要

情绪背景的变化对多发性硬化症(MS)的临床表现有重大影响,严重降低患者的生活质量,并在康复过程中阻碍适应。近年来,世界文献中讨论了精神状态与疾病活动之间的关系,认为MS中的精神障碍基于发病机制的观点越来越普遍。本文讨论了介导免疫反应的物质——细胞因子——在神经系统功能活动和心理情绪状态变化影响中的潜在作用。还讨论了它们可能参与MS使用β-干扰素和醋酸格拉替雷进行免疫调节治疗的副作用发病机制的问题。

相似文献

1
The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.细胞因子作为免疫调节疗法对多发性硬化症心理影响的一种可能底物的作用。
Neurosci Behav Physiol. 2009 Jan;39(1):25-30. doi: 10.1007/s11055-008-9087-1.
2
[A possible effect of the immunomodulating therapy with beta-interferons and glatimer acetate on the development of thyroid disease in patients with multiple sclerosis].
Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):58-67.
3
Current immunotherapy in multiple sclerosis.多发性硬化症的当前免疫疗法。
Immunol Cell Biol. 1998 Feb;76(1):55-64. doi: 10.1046/j.1440-1711.1998.00714.x.
4
Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis.干扰素和醋酸格拉替雷在多发性硬化症中的作用机制。
Neurology. 2002 Apr 23;58(8 Suppl 4):S3-9. doi: 10.1212/wnl.58.8_suppl_4.s3.
5
Multiple sclerosis: therapeutic update.多发性硬化症:治疗进展
Arch Neurol. 1999 Mar;56(3):277-80. doi: 10.1001/archneur.56.3.277.
6
A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis.干扰素β与醋酸格拉替雷治疗多发性硬化症的作用机制比较
Clin Ther. 2002 Dec;24(12):1998-2021. doi: 10.1016/s0149-2918(02)80094-7.
7
Relapsing MS patients' experiences with glatiramer acetate treatment: a phenomenological study.
J Neurosci Nurs. 2006 Feb;38(1):37-41. doi: 10.1097/01376517-200602000-00008.
8
What is new in the treatment of multiple sclerosis?多发性硬化症治疗方面有哪些新进展?
Drugs. 2000 Mar;59(3):401-10. doi: 10.2165/00003495-200059030-00002.
9
[The technology of treatment of multiple sclerosis with long-term immunomodulating drugs (disease modifying drugs--DMD)--beta-interferons and glatiramer-acetate].[使用长期免疫调节药物(疾病修正药物——DMD)——β-干扰素和醋酸格拉替雷治疗多发性硬化症的技术]
Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):86-92.
10
In the coming year we should abandon interferons and glatiramer acetate as first line therapy for MS: commentary.
Mult Scler. 2013 Jan;19(1):29-30. doi: 10.1177/1352458512470507.

本文引用的文献

1
Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder.创伤后应激障碍患者存在低度全身性促炎活性的证据。
J Psychiatr Res. 2007 Nov;41(9):744-52. doi: 10.1016/j.jpsychires.2006.06.009. Epub 2006 Aug 9.
2
Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.干扰素-β治疗的多发性硬化症患者免疫细胞迁移的动力学
J Neuroimmunol. 2003 Jun;139(1-2):84-92. doi: 10.1016/s0165-5728(03)00135-8.
3
The hypothalamo-pituitary-adrenal axis in multiple sclerosis.
多发性硬化症中的下丘脑 - 垂体 - 肾上腺轴
Ann N Y Acad Sci. 2003 May;992:118-28. doi: 10.1111/j.1749-6632.2003.tb03143.x.
4
Cytokines and cognition--the case for a head-to-toe inflammatory paradigm.细胞因子与认知——全身炎症范式之实例
J Am Geriatr Soc. 2002 Dec;50(12):2041-56. doi: 10.1046/j.1532-5415.2002.50619.x.
5
Neuropsychological performance and mood states following acute interferon-beta-1b administration in healthy males.健康男性急性注射β-干扰素-1b后的神经心理表现和情绪状态
Neuropsychobiology. 2002;45(4):199-204. doi: 10.1159/000063671.
6
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.
Psychoneuroendocrinology. 2001 Nov;26(8):797-808. doi: 10.1016/s0306-4530(01)00030-0.
7
Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression.
J Affect Disord. 2001 Oct;66(2-3):193-8. doi: 10.1016/s0165-0327(00)00298-6.
8
Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits.
Am J Physiol Regul Integr Comp Physiol. 2001 Sep;281(3):R1004-12. doi: 10.1152/ajpregu.2001.281.3.R1004.
9
CSF norepinephrine concentrations in posttraumatic stress disorder.创伤后应激障碍患者脑脊液中去甲肾上腺素的浓度
Am J Psychiatry. 2001 Aug;158(8):1227-30. doi: 10.1176/appi.ajp.158.8.1227.
10
[Spectrum of neuropsychological changes in multiple sclerosis].
Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(11):15-20.